Cargando…

Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer

SIMPLE SUMMARY: Multidrug resistance and infiltration/metastasis of cancer are two major issues that must be overcome during chemotherapy. Efflux transporters, such as P-glycoprotein (P-gp), multidrug resistance-associated proteins, and breast cancer resistance protein play an important role in mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogihara, Takuo, Mizoi, Kenta, Kamioka, Hiroki, Yano, Kentaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696277/
https://www.ncbi.nlm.nih.gov/pubmed/33198344
http://dx.doi.org/10.3390/cancers12113352
_version_ 1783615373510180864
author Ogihara, Takuo
Mizoi, Kenta
Kamioka, Hiroki
Yano, Kentaro
author_facet Ogihara, Takuo
Mizoi, Kenta
Kamioka, Hiroki
Yano, Kentaro
author_sort Ogihara, Takuo
collection PubMed
description SIMPLE SUMMARY: Multidrug resistance and infiltration/metastasis of cancer are two major issues that must be overcome during chemotherapy. Efflux transporters, such as P-glycoprotein (P-gp), multidrug resistance-associated proteins, and breast cancer resistance protein play an important role in multidrug resistance of cancer. The ERM scaffold protein ezrin, radixin, and moesin acts as an anchor to support the expression of these transporters on the cell membrane. This review summarizes the organ-specific relationship between efflux transporters and ERM proteins. Furthermore, we also describe how transcriptional regulatory factors such as Snail that play an active role in cancer metastasis, are involved in the activation of P-gp through the expression of ERM proteins. We hope that this review will be useful to many researchers in understanding how to overcome multidrug resistance in cancer. ABSTRACT: One factor contributing to the malignancy of cancer cells is the acquisition of drug resistance during chemotherapy via increased expression of efflux transporters, such as P-glycoprotein (P-gp), multidrug resistance-associated proteins (MRPs), and breast cancer resistance protein (BCRP). These transporters operate at the cell membrane, and are anchored in place by the scaffold proteins ezrin (Ezr), radixin (Rdx), and moesin (Msn) (ERM proteins), which regulate their functional activity. The identity of the regulatory scaffold protein(s) differs depending upon the transporter, and also upon the tissue in which it is expressed, even for the same transporter. Another factor contributing to malignancy is metastatic ability. Epithelial–mesenchymal transition (EMT) is the first step in the conversion of primary epithelial cells into mesenchymal cells that can be transported to other organs via the blood. The SNAI family, a transcriptional regulators triggers EMT, and SNAI expression is used is an indicator of malignancy. Furthermore, EMT has been suggested to be involved in drug resistance, since drug excretion from cancer cells is promoted during EMT. We showed recently that ERM proteins are induced by a member of the SNAI family, Snail. Here, we first review recent progress in research on the relationship between efflux transporters and scaffold proteins, including the question of tissue specificity. In the second part, we review the relationship between ERM scaffold proteins and the transcriptional regulatory factors that induce their expression.
format Online
Article
Text
id pubmed-7696277
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76962772020-11-29 Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer Ogihara, Takuo Mizoi, Kenta Kamioka, Hiroki Yano, Kentaro Cancers (Basel) Review SIMPLE SUMMARY: Multidrug resistance and infiltration/metastasis of cancer are two major issues that must be overcome during chemotherapy. Efflux transporters, such as P-glycoprotein (P-gp), multidrug resistance-associated proteins, and breast cancer resistance protein play an important role in multidrug resistance of cancer. The ERM scaffold protein ezrin, radixin, and moesin acts as an anchor to support the expression of these transporters on the cell membrane. This review summarizes the organ-specific relationship between efflux transporters and ERM proteins. Furthermore, we also describe how transcriptional regulatory factors such as Snail that play an active role in cancer metastasis, are involved in the activation of P-gp through the expression of ERM proteins. We hope that this review will be useful to many researchers in understanding how to overcome multidrug resistance in cancer. ABSTRACT: One factor contributing to the malignancy of cancer cells is the acquisition of drug resistance during chemotherapy via increased expression of efflux transporters, such as P-glycoprotein (P-gp), multidrug resistance-associated proteins (MRPs), and breast cancer resistance protein (BCRP). These transporters operate at the cell membrane, and are anchored in place by the scaffold proteins ezrin (Ezr), radixin (Rdx), and moesin (Msn) (ERM proteins), which regulate their functional activity. The identity of the regulatory scaffold protein(s) differs depending upon the transporter, and also upon the tissue in which it is expressed, even for the same transporter. Another factor contributing to malignancy is metastatic ability. Epithelial–mesenchymal transition (EMT) is the first step in the conversion of primary epithelial cells into mesenchymal cells that can be transported to other organs via the blood. The SNAI family, a transcriptional regulators triggers EMT, and SNAI expression is used is an indicator of malignancy. Furthermore, EMT has been suggested to be involved in drug resistance, since drug excretion from cancer cells is promoted during EMT. We showed recently that ERM proteins are induced by a member of the SNAI family, Snail. Here, we first review recent progress in research on the relationship between efflux transporters and scaffold proteins, including the question of tissue specificity. In the second part, we review the relationship between ERM scaffold proteins and the transcriptional regulatory factors that induce their expression. MDPI 2020-11-12 /pmc/articles/PMC7696277/ /pubmed/33198344 http://dx.doi.org/10.3390/cancers12113352 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ogihara, Takuo
Mizoi, Kenta
Kamioka, Hiroki
Yano, Kentaro
Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
title Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
title_full Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
title_fullStr Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
title_full_unstemmed Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
title_short Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
title_sort physiological roles of erm proteins and transcriptional regulators in supporting membrane expression of efflux transporters as factors of drug resistance in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696277/
https://www.ncbi.nlm.nih.gov/pubmed/33198344
http://dx.doi.org/10.3390/cancers12113352
work_keys_str_mv AT ogiharatakuo physiologicalrolesofermproteinsandtranscriptionalregulatorsinsupportingmembraneexpressionofeffluxtransportersasfactorsofdrugresistanceincancer
AT mizoikenta physiologicalrolesofermproteinsandtranscriptionalregulatorsinsupportingmembraneexpressionofeffluxtransportersasfactorsofdrugresistanceincancer
AT kamiokahiroki physiologicalrolesofermproteinsandtranscriptionalregulatorsinsupportingmembraneexpressionofeffluxtransportersasfactorsofdrugresistanceincancer
AT yanokentaro physiologicalrolesofermproteinsandtranscriptionalregulatorsinsupportingmembraneexpressionofeffluxtransportersasfactorsofdrugresistanceincancer